Safety and efficacy of sunitinib in patients from Italy with metastatic renal cell carcinoma: Final results from an expanded-access trial Academic Article uri icon

Overview

MeSH Major

  • Antineoplastic Agents
  • Carcinoma, Renal Cell
  • Indoles
  • Kidney Neoplasms
  • Pyrroles

abstract

  • In a large population of Italian mRCC patients, sunitinib had a manageable safety profile and encouraging efficacy.

publication date

  • January 2015

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1159/000369256

PubMed ID

  • 25592399

Additional Document Info

start page

  • 273

end page

  • 80

volume

  • 88

number

  • 5